A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma

Conditions: Hepatocellular Carcinoma; Advanced Hepatocellular Carcinoma; Liver Cancer Interventions: Drug: ETN101 Sponsors: Etnova Therapeutics Corp. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials